Search

Your search keyword '"Huang, Stacy"' showing total 3 results
Start Over Author "Huang, Stacy"
3 results on '"Huang, Stacy"'

1. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season

Author

Adams, Katherine, Tastad, Katie J, Huang, Stacy, Ujamaa, Dawud, Kniss, Krista, Cummings, Charisse, Reingold, Arthur, Roland, Jeremy, Austin, Elizabeth, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan J, Openo, Kyle P, Reeg, Libby, Leegwater, Lauren, McMahon, Melissa, Bye, Erica, Poblete, Mayvilynne, Landis, Zachary, Spina, Nancy L, Engesser, Kerianne, Bennett, Nancy M, Gaitan, Maria A, Shiltz, Eli, Moran, Nancy, Sutton, Melissa, Abdullah, Nasreen, Schaffner, William, Talbot, H Keipp, Olsen, Kristen, Staten, Holly, Taylor, Christopher A, Havers, Fiona P, Reed, Carrie, Budd, Alicia, Garg, Shikha, O’Halloran, Alissa, and Brammer, Lynnette

Subjects
Influenza, Pediatric, Immunization, Infectious Diseases, Biodefense, Emerging Infectious Diseases, Vaccine Related, Prevention, Lung, Pneumonia & Influenza, Infection, Good Health and Well Being, Child, Humans, Adolescent, United States, SARS-CoV-2, Influenza, Human, Coinfection, Seasons, Prevalence, COVID-19, Death, General & Internal Medicine
Abstract

The 2022-23 influenza season shows an early rise in pediatric influenza-associated hospitalizations (1). SARS-CoV-2 viruses also continue to circulate (2). The current influenza season is the first with substantial co-circulation of influenza viruses and SARS-CoV-2 (3). Although both seasonal influenza viruses and SARS-CoV-2 can contribute to substantial pediatric morbidity (3-5), whether coinfection increases disease severity compared with that associated with infection with one virus alone is unknown. This report describes characteristics and prevalence of laboratory-confirmed influenza virus and SARS-CoV-2 coinfections among patients aged

Published
2022

2. Influenza Activity and Composition of the 2022-23 Influenza Vaccine--United States, 2021-22 Season

Author

Merced-Morales, Angiezel, Daly, Peter, Elal, Anwar Isa Abd, Ajayi, Noreen, Annan, Ekow, Budd, Alicia, Barnes, John, Colon, Arielle, Cummings, Charisse N., Iuliano, A. Danielle, DaSilva, Juliana, Dempster, Nick, Garg, Shikha, Gubareva, Larisa, Hawkins, Daneisha, Howa, Amanda, Huang, Stacy, Kirby, Marie, Kniss, Krista, Kondor, Rebecca, Liddell, Jimma, Moon, Shunte, Nguyen, Ha. T., O'Halloran, Alissa, Smith, Catherine, Stark, Thomas, Tastad, Katie, Ujamaa, Dawud, Wentworth, Dave E., Fry, Alicia M., Dugan, Vivien G., and Brammer, Lynnette

Subjects
United States. Department of Health and Human Services, Influenza vaccines, Influenza, Health, World Health Organization
Abstract

Before the emergence of SARS-CoV-2, the virus that causes COVID-19, influenza activity in the United States typically began to increase in the fall and peaked in February. During the 2021-22 [...]

Published
2022

3. Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season.

Author

Merced-Morales A, Daly P, Abd Elal AI, Ajayi N, Annan E, Budd A, Barnes J, Colon A, Cummings CN, Iuliano AD, DaSilva J, Dempster N, Garg S, Gubareva L, Hawkins D, Howa A, Huang S, Kirby M, Kniss K, Kondor R, Liddell J, Moon S, Nguyen HT, O'Halloran A, Smith C, Stark T, Tastad K, Ujamaa D, Wentworth DE, Fry AM, Dugan VG, and Brammer L

Subjects
Humans, Influenza A Virus, H3N2 Subtype genetics, Influenza B virus genetics, Population Surveillance, SARS-CoV-2, Seasons, United States epidemiology, COVID-19, Influenza A Virus, H5N1 Subtype, Influenza Vaccines, Influenza, Human epidemiology, Influenza, Human prevention & control
Abstract

Before the emergence of SARS-CoV-2, the virus that causes COVID-19, influenza activity in the United States typically began to increase in the fall and peaked in February. During the 2021-22 season, influenza activity began to increase in November and remained elevated until mid-June, featuring two distinct waves, with A(H3N2) viruses predominating for the entire season. This report summarizes influenza activity during October 3, 2021-June 11, 2022, in the United States and describes the composition of the Northern Hemisphere 2022-23 influenza vaccine. Although influenza activity is decreasing and circulation during summer is typically low, remaining vigilant for influenza infections, performing testing for seasonal influenza viruses, and monitoring for novel influenza A virus infections are important. An outbreak of highly pathogenic avian influenza A(H5N1) is ongoing; health care providers and persons with exposure to sick or infected birds should remain vigilant for onset of symptoms consistent with influenza. Receiving a seasonal influenza vaccine each year remains the best way to protect against seasonal influenza and its potentially severe consequences., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results